Berry Cooper

As reported, a $300M settlement agreement was reached between Daiichi Sankyo and users of the popular high blood pressure drug, Benicar. BUT THERE'S A TIGHT DEADLINE! There are a group of plaintiffs who must act immediately. These are the plaintiffs who have not enrolled in the Program or filed suit. This group of people, are facing an extreme deadline. This group must retain legal counsel and file necessary documents no later than 11:59pm on August 23, 2017. Don't Miss This.

As reported Monday, a $300M settlement agreement was reached between Daiichi Sankyo and users of the popular high blood pressure drug, Benicar. BUT THERE'S A TIGHT DEADLINE! The settlement agreement may be read on a website, Olmesartan Products Litigation Settlement, established to facilitate payment of claims. Plaintiffs opting to enroll in the Olmesartan Products Resolution Program (at the website) must comply with enrollment requirements as spelled out on the site. However